Katherine Cilwa, PhD

Katherine Cilwa, PhD has a diverse work experience in the field of medical affairs, clinical research, and spectroscopy. Katherine is currently serving as the Medical Director of Medical Affairs at UroGen Pharma since September 2021. Prior to that, they worked as an Associate Director of Clinical Research at CG Oncology from May 2021 to September 2021.

From 2014 to 2021, Katherine was associated with The Henry M. Jackson Foundation for the Advancement of Military Medicine. During this time, they held multiple positions including Subject Matter Expert Consultant from February 2018 to June 2021, Advanced Surgical Imaging Program Lead from January 2016 to February 2018, and Research Raman Spectroscopist from January 2014 to December 2015.

In 2020, Katherine worked as a Medical Science Liaison at FerGene from March 2020 to March 2021. Prior to that, they served as a Medical Science Liaison at Photocure from February 2018 to March 2020.

Additionally, Katherine was a Board Member of the Governing Board and served as the Membership Committee Chair and Newsletter Editor at Coblentz Society from 2014 to 2019.

Katherine Cilwa, PhD obtained their PhD in Physical Chemistry from The Ohio State University. No specific start or end years were provided for their education.